Sunrise to expand clinical trials:
This article was originally published in Clinica
Executive Summary
Sunrise Technologies is to add 20 more patients to its current US clinical trial for treating presbyopia following a conditional approval from the FDA. The Fremont, California-based company treats patients, who suffer from a reduced ability to focus on close objects, with a Holmium laser system which uses a collagen-shrinking process called the Sand Process.